Switch to:
More From Other Websites
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks Sep 22 2016
Sarepta (SRPT) Stock Lower, BioMarin to Appeal Patent Ruling Sep 21 2016
Sarepta Therapeutics: BioMarin Still Wants a Piece of the Action Sep 21 2016
Patent Trial And Appeal Board Hands Sarepta Another Big Win Sep 21 2016
BioMarin Reviews Status of Exon 51 Composition of Matter and Method of Use Patent Interference Cases... Sep 21 2016
BioMarin Reviews Status of Exon 51 Composition of Matter and Method of Use Patent Interference Cases... Sep 21 2016
[$$] Sarepta Soars 100% in a Week Yet Remains a Buy Sep 20 2016
Why Sarepta Approval is Good News for BioMarin, Alexion Sep 20 2016
Biotech Stock Mailbag: Sarepta Therapeutics Approval Edition Sep 20 2016
Biomarin Pharmaceutical Inc (BMRN) CEO Jean Jacques Bienaime Sold $13.1 million of Shares Sep 19 2016
Sarepta Therapeutics: Wait, I Thought Turmoil at the FDA Was Good News? Sep 15 2016
BioMarin Pharmaceutical, Inc. – Value Analysis (NASDAQ:BMRN) : September 15, 2016 Sep 15 2016
BioMarin Announces EMA Validation of Brineura™ (Cerliponase Alfa) Marketing Authorization... Sep 15 2016
BioMarin Announces EMA Validation of Brineura™ (Cerliponase Alfa) Marketing Authorization... Sep 15 2016
SunTrust On Sarepta Therapeutics: FDA Likely To Deny Approval For Eteplirsen Sep 14 2016
[$$] Sarepta Rally Has Legs as FDA Critic Leaves Agency Sep 14 2016
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bearish Manner : BMRN-US :... Sep 14 2016
These 5 Biotech Stocks Are Ready for a Volatility Break Sep 14 2016
Low Valuation Ratios Lead to Strong Portfolio Returns Sep 13 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK